Strong YoY growth masks sequential deterioration; GST tailwind fading

Revenue ₹1888.3 Cr (+40.1%), PAT ₹162.9 Cr (+92.5%)

Delivered NPM 8.2%, not 9%. Margin did expand but claim overstates actual.

Management stated 'maybe at about half of that' = ~₹50 Cr, down from prior guidance

Q3/Q4 FY26 saw big demand, Q1 FY27 'already started to fade', uncertain for Q2. Tailwind is eroding.

Revenue -8.4% QoQ, PAT -37.6% QoQ. Fresh growth will be lower than renewal growth going forward.

Prior guidance ~₹100 Cr annually (implied from 'significantly profitable' commentary), now ~₹50 Cr. 50% cut.

Management stated fresh growth 'won't be as high' as 50%+ renewal growth. Implies deceleration from prior 39-48% run-rate.

Q3/Q4 FY26 saw surge, Q1 FY27 'already started to fade', uncertain for Q2. Tailwind acknowledged as short-term only.

30-40% of 10 Cr monthly interactions now AI-touched; sales productivity, risk screening, service automation showing wins.

Now 65-70% of online business vs earlier lower mix. South growing faster than North. Market share gains in underpenetrated geographies.

Three drivers: aggressive demand creation & marketing spend; attractively priced, tailored products; superior claims service. 82% of inflow is new-to-insurance. Monthly mode (30% of health) and maternity innovation (3-month vs 1-2yr waiting) driving affordability.

Renewals growth will beat fresh for 12 months+, but we're increasing acquisition spend. Not pursuing short-term efficiency; targeting lifetime value. Margin expansion will come from growth, not contraction at lower growth.

Legally, broker must put maximum effort per regulator. We've had two demand spikes (COVID, GST) that faded. Effort required to sell insurance is high—we make 1-2% margin after 18 years. If anyone can do better, welcome. Don't anticipate major change.

Supporting 100% of claims that reach us. ~1.25-1.67% of base claims per quarter, ~6% annually. Settlement is complex; most claims self-resolve; we're a fallback for stuck/disputed claims. Effort-intensive per claim.

Motor + two-wheeler direct grew >30%, POSP grew ~50%. Dependent on new car/bike sales; we're rollover player. Gaining share modestly each quarter. Will continue.

Just approved second hospital billing. Fitterfly revenue up 4x since acquisition. Internal targets: ₹500 Cr annual run-rate by Mar'27, break-even. Opened 1-2 hospitals from scratch, others in pipeline. One year in; healthcare is complex but working.

Fresh growth 20% despite choppy markets. Two developments: (1) Waiver of Premium concept expanded beyond children—60%+ of domestic business now in July; (2) GIFT City launch Sept 2025—dollar plans, non-residents repurchasing. Both positive for forward growth.

Daily SIP for self-employed (lower monthly income visibility). No pilot; learning from Policybazaar. Industry growing 20-22% YoY. Won't be >5-10% of Paisa revenue in 2 years, possibly 10-15% at best. Savings stickiness-building, not revenue-building short-term.

Maybe at about half of that [~₹50 Cr]. Broke even in Q1. [Implicit 50% guidance cut from prior ₹100 Cr annual target.]

Operating system restructure ongoing. 30-40% of 10 Cr monthly interactions now AI-touched. Sales productivity gains (advisors see relevant info in real-time), risk screening (saved ₹10k Cr sum assured), service automation (20-30% interactions auto-handled). Focus on outcomes, not token burn. Goal: A+ customer experience.

No deception; phone number requirement is transparent on first page. Generating enquiries is high-effort; phone is essential. UK market (MoneySuperMarket, Confused.com) also collect without dark pattern concerns. Will let courts decide if any issue arises.

Q3 was above-trend due to GST. We target 30% growth and have beaten it historically. Will maintain above-market growth. Not calling it slowdown; goal is consistent above-market performance.

Revenue grew 40-46%, costs grew ~35%. No particular cost reduction effort yet. 'Haven't started to fight yet'—efficiency will come later. Q1 is weakest quarter; hired 5,000 people gross in Q1 despite seasonality. Not optimizing for cost yet.

Reducing top 100 concentration by expanding partner base (1.2-1.4 Lac partners vs ~12 Lac total GI agents). Focus is scale, not profitability. Willing to invest as long as it's an investment in capability, not expense.

Brand new ticket sizes will go up (good for new players). Real opportunity if enforcement rises (per judgment, fuel not sold without TP insurance, etc). If enforcement is high like 2019 post-Motor Vehicle Act, meaningful jump possible. Too early to call.

We broke even [in Q1]. Didn't directly answer full-year, but context of 'maybe half' implies ~₹50 Cr annual guidance, revised down from prior ₹100 Cr.

Prior guidance maintained but with caveats. Fresh growth will decelerate post-GST tailwind fade. Q3 FY26 was 'above trend' demand spike.

Management stated not pursuing short-term efficiency; increasing acquisition spend. PAT margin 8.2% delivered (vs 9% claimed) suggests limited near-term expansion.

GST-driven demand surge in Q3/Q4 FY26 is 'already starting to fade' in Q1 FY27. Q2 outlook 'uncertain'. Management acknowledged insurance demand is 'extremely low' and dependent on regulatory tailwinds.

Regulator discussing effort-based commission cuts, potentially asymmetric by channel (banks vs aggregators vs manufacturers). Separate dark patterns debate on phone number collection for quotes. Management deflected but acknowledged uncertainty.

Prior guidance: ~₹100 Cr EBITDA annually for Paisabazaar. Management now states 'maybe at about half of that' = ~₹50 Cr. 50% reduction not proactively communicated; investor had to ask.

PAT ₹162.9 Cr down 37.6% QoQ; revenue down 8.4% QoQ. Signals sharp seasonality and cyclicality. Q1 is weakest quarter of year but magnitude of decline is notable.

Management stated PAT margin improved to 9%, but delivered NPM is 8.2%—an 80 bps gap. Margin expansion story may be overstated. Management stated increasing acquisition spend; margins won't expand significantly near-term.